Study Finds New Therapy Effective for Common, Advanced Bladder Cancer

Following standard chemotherapy, Avelumab was found to increase the overall survival of patients with advanced urothelial bladder cancer. According to the North American Association of Central Cancer Registries, more than 80,000 Americans will be diagnosed with bladder cancer in 2022 with an anticipated loss of 17,000 patients to the disease. Most of these cases are…

Read More

Tips to Healthy Eating During Cancer Treatment

Angie Lord, RD, is a registered dietitian at the Inova Schar Cancer Institute and Life With Cancer. She is also a registered yoga teacher. Angie enjoys helping patients meet their nutritional needs while receiving cancer treatment and loves learning about patients’ stories and backgrounds during her time with them. Each March, the Academy of Nutrition…

Read More

Inova Schar Cancer Institute Accepting Participants in Early Detection Study for Pancreatic Cancer

Raymond Wadlow, MD, is an oncologist at Inova Schar Cancer Institute. He is board-certified in Medical Oncology and Internal Medicine and has a special interest in gastrointestinal oncology.  If you are interested in participating in this study on pancreatic cancer, visit the Inova Saville Cancer Screening and Prevention Center to learn more. The pancreas is…

Read More

Eat to Thrive: Putting Oncology Evidence into Practice

Lauren Fay, RD, CSO, CNSC, is a registered dietitian at the Inova Schar Cancer Institute and Life With Cancer. She is board-certified in oncology nutrition and nutrition support. One of the largest challenges cancer survivors face is understanding correctly interpreted nutrition science, and then putting this information into practice. Inova Schar Cancer Institute and Life with…

Read More

How the Life with Cancer® Program Serves and Supports Inova Patients and Families

Kelly Jablonski, MSW, LCSW, is an Oncology Clinical Therapist at Inova Life with Cancer. She provides supportive counseling, education and resources to individuals diagnosed with breast cancer at the Adult Infusion Clinic at Inova Schar Cancer Institute. Going through cancer treatment can be overwhelming and emotional, whether you’re a patient or family member. Having a…

Read More

Inova Announces Gift to Endow Sheridan Director, Molecular Tumor Board at Inova Schar Cancer Institute

Falls Church, VA —Inova today announced that it has received a $1 million gift from Win Sheridan, co-founder of APEX Systems, to endow the role of the Director of the Molecular Tumor Board at Inova Schar Cancer Institute. In recognition of Sheridan’s generous gift, this position will be renamed to be the Sheridan Director, Molecular…

Read More

How to Tell Your Child About Your Cancer Diagnosis

father embracing son

Practical Strategies for Tough Conversations By Amanda L. Thompson, PhD, and Shari Langer, PsyD Amanda Thompson, PhD, is the Chief of Pediatric Psychology and Director of Pediatric Programs for Life with Cancer, a program of the Inova Schar Cancer Institute. Shari Langer, PsyD, is a pediatric psychologist with Life with Cancer at the Inova L.J.…

Read More

Direct-to-Consumer Genetic Testing for Inherited Cancer Risk

Morgan Turner, MS, CGC, is a Virginia-licensed and nationally board-certified, cancer-specialized genetic counselor at Inova Schar Cancer Institute. She joined Inova in June 2018. Many patients are surprised to learn that the majority of people who are diagnosed with a cancer do not have a genetic (or inherited) cause for their cancer. Indeed, it is…

Read More

Inova Schar Cancer Institute Radiation Oncology Achieves Four-Year Accreditation for Radiation Oncology Services from ASTRO’s APEx – Accreditation Program for Excellence®

Falls Church, VA – Inova is proud to announce that all five radiation oncology departments within the Inova Schar Cancer Institute (ISCI) have been reaccredited by the American Society for Radiation Oncology (ASTRO) for APEx – Accreditation Program for Excellence®. APEx is an accreditation program developed by ASTRO that validates a radiation oncology facility’s excellence…

Read More

Early Study Finds MGC018 Active in Resistant Skin Cancer

Sekwon Jang, MD in medical oncology at Inova Schar Cancer Institute, presented the latest data on the multi-institutional Phase 1 clinical trial for MGC018 at the annual American Society of Clinical Oncology held June 4–8, 2021. What is MGC018? MGC018 is an investigational drug developed by MacroGenics that is being studied for the treatment of…

Read More